Literature DB >> 6284410

Demonstration of circulating 1,24,25-trihydroxyvitamin D3 in man by radioimmunoassay.

T L Clemens, L J Fraher, L M Sandler, J L O'Riordan.   

Abstract

1,24,25-trihydroxyvitamin D3 has been detected in human serum using a sensitive radioimmunoassay. Tritiated 1,24,25-trihydroxyvitamin D3 was synthesized biologically and used as tracer to monitor the recovery of endogenous metabolite during isolation from serum. Circulating 1,24,25(OH)3D3 in normal subjects ranged from 9.3 to 18.5 pmol/l but was not detectable (less than 2.3 pmol/l) in serum from nephrectomized subjects. The trihydroxymetabolite was elevated in three out of four vitamin D deficient subjects who were being treated with vitamin D3.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284410     DOI: 10.1111/j.1365-2265.1982.tb00725.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application.

Authors:  D Tartarotti; S Adami; G Galvanini; R Dorizzi; G Piemonte; V Lo Cascio
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

2.  Effects of vitamin D3 metabolites on thyrotropin secretion from rat pituitary cells in culture.

Authors:  K Törnquist; L Forss; C Lamberg-Allardt
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

3.  Calcitriol/calcifediol ratio: An indicator of vitamin D hydroxylation efficiency?

Authors:  Marzia Pasquali; Lida Tartaglione; Silverio Rotondi; Maria Luisa Muci; Giusi Mandanici; Alessio Farcomeni; Martino Marangella; Sandro Mazzaferro
Journal:  BBA Clin       Date:  2015-03-14

Review 4.  Diagnostic Aspects of Vitamin D: Clinical Utility of Vitamin D Metabolite Profiling.

Authors:  Glenville Jones; Martin Kaufmann
Journal:  JBMR Plus       Date:  2021-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.